Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
129
-
Total 13F shares, excl. options
-
64,099,042
-
Shares change
-
-3,703,103
-
Total reported value, excl. options
-
$328,177,512
-
Value change
-
-$24,948,443
-
Put/Call ratio
-
0%
-
Number of buys
-
59
-
Number of sells
-
-51
-
Price
-
$5.12
Significant Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2019
152 filings reported holding CBAY - CYMABAY THERAPEUTICS INC - COM as of Q3 2019.
CYMABAY THERAPEUTICS INC - COM (CBAY) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64,099,042 shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (5,707,411 shares), BlackRock Inc. (5,628,239 shares), MILLENNIUM MANAGEMENT LLC (3,723,797 shares), VANGUARD GROUP INC (3,677,394 shares), Point72 Asset Management, L.P. (3,160,600 shares), Redmile Group, LLC (3,115,865 shares), Avoro Capital Advisors LLC (2,700,000 shares), EAGLE ASSET MANAGEMENT INC (2,334,861 shares), CITADEL ADVISORS LLC (2,292,340 shares), and CARILLON TOWER ADVISERS, INC. (2,061,772 shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.